
|Videos|October 20, 2017
Older HPV-Positive Oropharyngeal Cancer Patients Have High Treatment Tolerability
Author(s)Richard Bakst, MD
This video examines results of a study that looked at treatment tolerability in elderly patients with HPV-positive oropharyngeal squamous cell carcinoma.
Advertisement
In this video, Richard Bakst, MD, of the Icahn School of Medicine at Mount Sinai in New York, discusses a study that examined treatment tolerability and outcomes in elderly patients (65 years and older) with human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma.
Bakst presented the results of the study (
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Relacorilant Combo in Platinum-Resistant Ovarian Cancers
2
FDA Clears Investigator-Initiated IND for SRN-101 in Recurrent High-Grade Glioma
3
Navigating New Horizons in Neuroendocrine Prostate Cancer
4
The Evolution of Artificial Intelligence in Oncology: Impact on Trials, Workflows, and Outcomes
5























































